Rare co-operation breathes life into generic-drug bill

OTTAWA - NDP House Leader Libby Davies persuaded the other parties to allow her NDP colleague Paul Dewar to be recognized as the bill’s new sponsor. Mr. Dewar has a slot near the top of Parliament’s order of precedence for private members’ bills, which means Bill C-393 could go to a final vote as early as March. “We saw proof today that Parliamentarians really can get things done together,” NDP industry critics Brian Masse, who has been fighting for the bill since Ms. Wasylycia-Leis’s departure, said in a press release.